Document Detail


Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists.
MedLine Citation:
PMID:  7902813     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Microdialysis and high pressure liquid chromatography were used to assess the effects of ventral tegmental area microinjections of the mu-opioid receptor antagonists D-Pen-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) and beta-funaltrexamine (beta-FNA) on extracellular ventral striatal dopamine and metabolite concentrations. While CTOP is known to antagonize the increases in extracellular ventral striatal dopamine and dopamine metabolite concentrations induced by ventral tegmental area microinjections of a mu-opioid receptor agonist, it produced dose-orderly increases in ventral striatal dopamine and dopamine metabolite concentrations when administered by itself. beta-FNA also elevated dopamine and metabolite concentrations. These mu-agonist-like effects of the mu-opioid receptor antagonists were unexpected and suggest that a complex local circuitry mediates opioid-dopamine interactions in the ventral tegmental area. Since mu-opioids are known to act on ventral tegmental neurons that contain gamma-aminobutyric acid (GABA), a model of interactions between GABAergic afferents to the ventral tegmental area and ventral tegmental GABAergic interneurons is proposed.
Authors:
D P Devine; P Leone; R A Wise
Related Documents :
16968603 - Ileal brake: neuropeptidergic control of intestinal transit.
19416973 - Differential modulation of mu- and delta-opioid receptor agonists by endogenous rgs4 pr...
12859683 - Chronic ethanol consumption enhances internalization of alpha1 subunit-containing gabaa...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  European journal of pharmacology     Volume:  243     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  1993 Oct 
Date Detail:
Created Date:  1994-01-12     Completed Date:  1994-01-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  55-64     Citation Subset:  IM    
Affiliation:
Department of Psychology, Concordia University, Montreal, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Animals
Dopamine / analysis,  physiology*
Injections, Intraventricular
Male
Microdialysis
Molecular Sequence Data
Naltrexone / administration & dosage,  analogs & derivatives,  pharmacology
Narcotic Antagonists / administration & dosage,  pharmacology
Nucleus Accumbens / chemistry,  drug effects*
Rats
Rats, Inbred Strains
Receptors, Opioid, mu / antagonists & inhibitors*
Somatostatin / administration & dosage,  analogs & derivatives*,  pharmacology
Ventral Tegmental Area / chemistry,  drug effects*
gamma-Aminobutyric Acid / physiology
Grant Support
ID/Acronym/Agency:
DA 01720/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Narcotic Antagonists; 0/Receptors, Opioid, mu; 103429-31-8/phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide; 16590-41-3/Naltrexone; 51110-01-1/Somatostatin; 56-12-2/gamma-Aminobutyric Acid; 72782-05-9/beta-funaltrexamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro.
Next Document:  Comparison of responses to pituitary adenylate cyclase activating peptides 38 and 27 in the pulmonar...